← Leaderboards
Thomas J Wang
Ut Southwestern Medical Center
$21,119,622
Attributed
$38,713,787
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,713,787 · 20
By mechanism
R01$33,966,283 · 12
T32$2,090,924 · 1
K12$1,742,928 · 1
K23$539,229 · 1
K08$360,932 · 1
M01$13,491 · 4
Top collaborators
- Robert E Gerszten26 shared
- James Graham Wilson8 shared
- Xiao-Ou Shu6 shared
- Clary B Clish5 shared
- Ambarish Pandey5 shared
- Ravi Thadhani5 shared
- Evan L Brittain4 shared
- Christopher Holmes Newton-Cheh4 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ambarish Pandey$2,438,022
- Kalil G Abdullah$1,835,946
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelRisk FactorsBaseCohortGeneticParticipantFollow-UpBiological MarkersDiabetes MellitusInvestigationPathway InteractionsCommunitiesTraitSamplingObesityPlasmaMetabolomicsFramingham Heart StudyResponseMetabolicRandomizedPhenotypeInsightCells
Grant awards (82)
Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population$735,237
R01 · FY2025 · MD
Polypill strategy for the treatment of patients after acute coronary syndromes - A multicenter randomized controlled trial$730,276
R01 · FY2025 · HL
Metabolomic predictors of insulin resistance and diabetes$649,027
R01 · FY2025 · DK
Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population$696,602
R01 · FY2024 · MD
Metabolomic predictors of insulin resistance and diabetes$598,445
R01 · FY2024 · DK
Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population$717,793
R01 · FY2023 · MD
Metabolomic predictors of insulin resistance and diabetes$621,278
R01 · FY2023 · DK
Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population$751,098
R01 · FY2022 · MD
Metabolomic predictors of insulin resistance and diabetes$621,842
R01 · FY2022 · DK
Metabolomic predictors of insulin resistance and diabetes$680,498
R01 · FY2021 · DK
Proteomic Pathway Discovery in Cardiovascular Disease$823,244
R01 · FY2019 · HL
PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction$728,870
R01 · FY2019 · HL · contact PI
The Vanderbilt Emergency Care Research Training Program$626,236
K12 · FY2019 · HL
Tissue Sodium, Inflammation, and Blood Pressure in MESA$464,863
R01 · FY2019 · HL
Metabolite profiles and the risk of diabetes in Asians$441,851
R01 · FY2019 · DK · contact PI
Metabolite profiles and the risk of diabetes in Asians$191,052
R01 · FY2019 · DK · contact PI
Proteomic Pathway Discovery in Cardiovascular Disease$839,937
R01 · FY2018 · HL
Tissue Sodium, Inflammation, and Blood Pressure in MESA$734,938
R01 · FY2018 · HL · contact PI
PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction$728,848
R01 · FY2018 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$666,859
R01 · FY2018 · DK
Metabolite profiles and the risk of diabetes in Asians$605,033
R01 · FY2018 · DK · contact PI
The Vanderbilt Emergency Care Research Training Program$561,290
K12 · FY2018 · HL
Training in Cardiovascular Research$390,896
T32 · FY2018 · HL · contact PI
Proteomic Pathway Discovery in Cardiovascular Disease$852,827
R01 · FY2017 · HL
Tissue Sodium, Inflammation, and Blood Pressure in MESA$745,273
R01 · FY2017 · HL · contact PI
PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction$693,135
R01 · FY2017 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$666,859
R01 · FY2017 · DK
Metabolite profiles and the risk of diabetes in Asians$655,327
R01 · FY2017 · DK · contact PI
Training in Cardiovascular Research$496,836
T32 · FY2017 · HL · contact PI
The Vanderbilt Emergency Care Research Training Program$472,232
K12 · FY2017 · HL
Training in Cardiovascular Research$1,512
T32 · FY2017 · HL · contact PI
Proteomic Pathway Discovery in Cardiovascular Disease$880,947
R01 · FY2016 · HL
Tissue Sodium, Inflammation, and Blood Pressure in MESA$793,066
R01 · FY2016 · HL · contact PI
PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction$777,818
R01 · FY2016 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$675,687
R01 · FY2016 · DK
Metabolite profiles and the risk of diabetes in Asians$669,827
R01 · FY2016 · DK · contact PI
Training in Cardiovascular Research$496,577
T32 · FY2016 · HL · contact PI
The Vanderbilt Emergency Care Research Training Program$83,170
K12 · FY2016 · HL
Metabolite profiles and the risk of diabetes in Asians$1
R01 · FY2016 · DK · contact PI
Metabolomic predictors of insulin resistance and diabetes$728,258
R01 · FY2015 · DK
Training In Cardiovascular Research$354,352
T32 · FY2015 · HL · contact PI
Impact of vitamin D supplementation on cardiac structure and function$264,464
R01 · FY2015 · HL · contact PI
Impact of vitamin D supplementation on cardiac structure and function$32,241
R01 · FY2015 · HL · contact PI
Obesity, salt-sensitivity, and the natriuretic peptides$576,739
R01 · FY2014 · HL · contact PI
Training in Cardiovascular Research$350,751
T32 · FY2014 · HL · contact PI
Impact of vitamin D supplementation on cardiac structure and function$294,801
R01 · FY2014 · HL · contact PI
Physiologic effects of natriuretic peptide genetic variation$716,806
R01 · FY2013 · HL
Metabolomic predictors of insulin resistance and diabetes$467,544
R01 · FY2013 · DK · contact PI
Obesity, salt-sensitivity, and the natriuretic peptides$378,714
R01 · FY2013 · HL · contact PI
Impact of vitamin D supplementation on cardiac structure and function$286,325
R01 · FY2013 · HL · contact PI
Physiologic effects of natriuretic peptide genetic variation$754,786
R01 · FY2012 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$481,852
R01 · FY2012 · DK · contact PI
Obesity, salt-sensitivity, and the natriuretic peptides$396,379
R01 · FY2012 · HL · contact PI
Impact of vitamin D supplementation on cardiac structure and function$307,048
R01 · FY2012 · HL · contact PI
Physiologic effects of natriuretic peptide genetic variation$756,716
R01 · FY2011 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$636,575
R01 · FY2011 · DK
Obesity, salt-sensitivity, and the natriuretic peptides$357,663
R01 · FY2011 · HL · contact PI
Physiologic effects of natriuretic peptide genetic variation$670,611
R01 · FY2010 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$608,636
R01 · FY2010 · DK
Nutriuretic Peptides, the Renin-Angiotensin System, and Metabolic Risk in Obesity$425,875
R01 · FY2010 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$596,402
R01 · FY2009 · DK
Nutriuretic Peptides, the Renin-Angiotensin System, and Metabolic Risk in Obesity$428,000
R01 · FY2009 · HL · contact PI
Endothelial Progenitor Cells: Clinical Correlates and Prognosis in the Community$297,049
R01 · FY2009 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$609,852
R01 · FY2008 · DK
Endothelial Progenitor Cells: Clinical Correlates and Prognosis in the Community$547,173
R01 · FY2008 · HL · contact PI
Nutriuretic Peptides, the Renin-Angiotensin System, and Metabolic Risk in Obesity$429,875
R01 · FY2008 · HL · contact PI
Metabolomic predictors of insulin resistance and diabetes$17,583
R01 · FY2008 · DK
NATRIURETIC PEPTIDE RESPONSE TO SALINE INFUSION$1,457
M01 · FY2008 · RR · contact PI
Endothelial Progenitor Cells: Clinical Correlates and Prognosis in the Community$519,981
R01 · FY2007 · HL · contact PI
Nutriuretic Peptides, the Renin-Angiotensin System, and Metabolic Risk in Obesity$449,125
R01 · FY2007 · HL · contact PI
Natriuretic Peptides, Genes, and Diastolic Heart Failure$20,895
K23 · FY2007 · HL · contact PI
NATRIURETIC PEPTIDE RESPONSE TO SALINE INFUSION$2,250
M01 · FY2007 · RR · contact PI
Endothelial Progenitor Cells: Clinical Prognosis$490,852
R01 · FY2006 · HL · contact PI
Natriuretic Peptides, Genes, and Diastolic Heart Failure$129,840
K23 · FY2006 · HL · contact PI
FUSION II$7,393
M01 · FY2006 · RR · contact PI
Natriuretic Peptides, Genes, and Diastolic Heart Failure$129,820
K23 · FY2005 · HL
Novel Confocal Microscope for Molecular/Cellular Imaging$123,791
K08 · FY2005 · DK
FUSION II$2,391
M01 · FY2005 · RR
Natriuretic Peptides, Genes, and Diastolic Heart Failure$129,642
K23 · FY2004 · HL
Novel Confocal Microscope for Molecular/Cellular Imaging$119,950
K08 · FY2004 · DK
Natriuretic Peptides, Genes, and Diastolic Heart Failure$129,032
K23 · FY2003 · HL
Novel Confocal Microscope for Molecular/Cellular Imaging$117,191
K08 · FY2003 · DK